Point of Care for Sepsis Diagnostics Market Research Report – Segmented By Diagnostic Method (Biomarker Test, Molecular Diagnostics, Immunoassays, and Others), By End-User (Hospitals & Clinics, Homecare, Research Laboratories, and Others), By Pathogen (Bacteria, Fungal, and Viral), By Age (Pediatric, Adult, and Geriatric), and Region- Size, Share, Growth Analysis | Forecast (2024 – 2030)

Chapter 1. Point of Care for Sepsis Diagnostics Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources 
Chapter 2. Point of Care for Sepsis Diagnostics Market – Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
         2.2.1    Demand Side
         2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. Point of Care for Sepsis Diagnostics Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis 
Chapter 4. Point of Care for Sepsis Diagnostics Market Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
         4.5.1    Bargaining Power of Suppliers
         4.5.2    Bargaining Powers of Customers
         4.5.3    Threat of New Entrants
         4.5.4    Rivalry among Existing Players
         4.5.5    Threat of Substitutes 
Chapter 5. Point of Care for Sepsis Diagnostics Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Point of Care for Sepsis Diagnostics Market – By Diagnostic Method
6.1    Introduction/Key Findings   
6.2    Biomarker Test
6.3    Molecular Diagnostics
6.4    Immunoassays
6.5    Others 
6.6    Y-O-Y Growth trend Analysis By Diagnostic Method
6.7    Absolute $ Opportunity Analysis By Diagnostic Method, 2024-2030 
Chapter 7. Point of Care for Sepsis Diagnostics Market – By End-User
7.1    Introduction/Key Findings   
7.2    Hospitals & Clinics
7.3    Homecare
7.4    Research Laboratories
7.5    Others
7.6    Y-O-Y Growth  trend Analysis By End-User
7.7    Absolute $ Opportunity Analysis By End-User, 2024-2030
 Chapter 8. Point of Care for Sepsis Diagnostics Market – By Pathogen
8.1    Introduction/Key Findings   
8.2    Bacteria
8.3    Fungal
8.4    Viral
8.5    Y-O-Y Growth trend Analysis By Pathogen
8.6    Absolute $ Opportunity Analysis By Pathogen, 2024-2030
Chapter 9. Point of Care for Sepsis Diagnostics Market – By Age
9.1    Introduction/Key Findings   
9.2    Pediatric
9.3    Adult
9.4    Geriatric
9.5    Y-O-Y Growth trend Analysis End-User
9.6    Absolute $ Opportunity Analysis End-User, 2024-2030 
Chapter 10. Point of Care for Sepsis Diagnostics Market, By Geography – Market Size, Forecast, Trends & Insights
10.1    North America
         10.1.1    By Country
                  10.1.1.1    U.S.A.
                  10.1.1.2    Canada
                  10.1.1.3    Mexico
         10.1.2    By Diagnostic Method
                  10.1.2.1    By Age
                  10.1.3    By By Pathogen
10.2    By End-User
         10.2.1    Countries & Segments - Market Attractiveness Analysis
10.3    Europe
         10.3.1    By Country
                  10.3.1.1    U.K
                  10.3.1.2    Germany
                  10.3.1.3    France
                  10.3.1.4    Italy
                  10.3.1.5    Spain
                  10.3.1.6    Rest of Europe
                  10.3.2    By Diagnostic Method
                  10.3.3    By End-User
                  10.3.4    By By Pathogen
                  10.3.5    By Age
                  10.3.6    Countries & Segments - Market Attractiveness Analysis
10.4    Asia Pacific
                  10.4.1    By Country
                  10.4.1.1    China
                  10.4.1.2    Japan
                  10.4.1.3    South Korea
                  10.4.1.4    India      
                  10.4.1.5    Australia & New Zealand
                  10.4.1.6    Rest of Asia-Pacific
         10.4.2    By Diagnostic Method
         10.4.3    By End-User
         10.4.4    By By Pathogen
         10.4.5    By Age
         10.4.6    Countries & Segments - Market Attractiveness Analysis
10.5    South America
         10.5.1    By Country
                  10.5.1.1    Brazil
                  10.5.1.2    Argentina
                  10.5.1.3    Colombia
                  10.5.1.4    Chile
                  10.5.1.5    Rest of South America
         10.5.2    By Diagnostic Method
         10.5.3    By End-User
         10.5.4    By By Pathogen
         10.5.5    By Age
         10.5.6    Countries & Segments - Market Attractiveness Analysis
10.6    Middle East & Africa
         10.6.1    By Country
                  10.6.1.1    United Arab Emirates (UAE)
                  10.6.1.2    Saudi Arabia
                  10.6.1.3    Qatar
                  10.6.1.4    Israel
                  10.6.1.5    South Africa
                  10.6.1.6    Nigeria
                  10.6.1.7    Kenya
                  10.6.1.8    Egypt
                  10.6.1.9    Rest of MEA
         10.6.2    By Diagnostic Method
         10.6.3    By End-User
         10.6.4    By By Pathogen
         10.6.5    By Age
         10.6.6    Countries & Segments - Market Attractiveness Analysis 
Chapter 11. Point of Care for Sepsis Diagnostics Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
11.1    Siemens
11.2    Abbott
11.3    AdvanDx
11.4    Miacom Diagnostics
11.5    Biofire Diagnostics
11.6    Alteco Medical
11.7    Becton Dickinson
11.8    Wolters Kluwer
11.9    Immunexpress
11.10    Inflammatix
11.11    Mbio
11.12    Abionic


 

Download Sample

The field with (*) is required.

Choose License Type

$

2850

$

5250

$

4500

$

1800

Frequently Asked Questions

 The Point of Care For Sepsis Diagnostics Market was valued at USD 470 million and is projected to reach a market size of USD 1001.64 million by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 9.92%. 

 Increasing cases of sepsis and the Rising geriatric population are the market drivers of the Point of Care For Sepsis Diagnostics market.

 Biomarker Tests, Molecular Diagnostics, Immunoassays, and Others, are the segments under the Point of Care For Sepsis Diagnostics Market by diagnostic method.

 North America is the most dominant region for the Point of Care For Sepsis Diagnostics Market.

Asia-Pacific is the fastest growing region in the Point of Care For Sepsis Diagnostics Market.